These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 5660429)
1. A comparison of action of dexamethasone and medrysone on human intraocular pressure. Drance SM; Scott S Can J Ophthalmol; 1968 Apr; 3(2):159-61. PubMed ID: 5660429 [No Abstract] [Full Text] [Related]
2. [Spersadex and Spersadex with chloramphenicol eyedrops]. Horven I Tidsskr Nor Laegeforen; 1974 Apr; 94(12):789-90. PubMed ID: 4830344 [No Abstract] [Full Text] [Related]
3. [Effects of a new corticosteroid "Medrysone" on intraocular pressure]. Kitazawa Y; Nose H; Chatranonta T Nihon Ganka Kiyo; 1971 Dec; 22(12):1073-7. PubMed ID: 5169300 [No Abstract] [Full Text] [Related]
7. Lowering of intraocular pressure in the untreated eye after the use of topical steroids. Das SN; Hitchings RA Br J Ophthalmol; 1971 Mar; 55(3):161-4. PubMed ID: 5575216 [No Abstract] [Full Text] [Related]
8. Corticosteroid therapy of eye disease. Fifty years later. Raizman M Arch Ophthalmol; 1996 Aug; 114(8):1000-1. PubMed ID: 8694704 [No Abstract] [Full Text] [Related]
9. Systemic steroids and ocular fluid dynamics. II. Systemic versus topical steroids. Godel V; Feiler-Ofry V; Stein R Acta Ophthalmol (Copenh); 1972; 50(5):664-76. PubMed ID: 4678542 [No Abstract] [Full Text] [Related]
10. On the nature of corticosteroid responsiveness. Iwata K Acta Med Biol (Niigata); 1971 Sep; 19(2):147-50. PubMed ID: 5147720 [No Abstract] [Full Text] [Related]
12. The clinical efficacy of medrysone, a new ophthalmic steroid. Dorsch W; Thygeson P Am J Ophthalmol; 1968 Jan; 65(1):74-5. PubMed ID: 5638193 [No Abstract] [Full Text] [Related]
13. [Therapeutic experiences with Corti-Biciron ophthalmic ointment]. RĂ¼ger K Dtsch Med J; 1970 Dec; 21(23):1462 passim. PubMed ID: 4321175 [No Abstract] [Full Text] [Related]
14. A case hypersensitive to bimatoprost and dexamethasone. Li X; Liu G; Wang Y; Yu W; Xiang H; Liu X J Ocul Pharmacol Ther; 2011 Oct; 27(5):519-23. PubMed ID: 21936632 [TBL] [Abstract][Full Text] [Related]
16. Twin study on ocular pressure following topically applied dexamethasone. II. Inheritance of variation in pressure response. Schwartz JT; Reuling FH; Feinleib M; Garrison RJ; Collie DJ Arch Ophthalmol; 1973 Oct; 90(4):281-6. PubMed ID: 4795755 [No Abstract] [Full Text] [Related]
17. Effects of dexamethasone, progesterone, and testosterone on IOP and GAGs in the rabbit eye. Knepper PA; Collins JA; Frederick R Invest Ophthalmol Vis Sci; 1985 Aug; 26(8):1093-100. PubMed ID: 3926712 [TBL] [Abstract][Full Text] [Related]
18. The treatment of ocular inflammation with medrysone. Bedrossian RH; Eriksen SP Arch Ophthalmol; 1969 Feb; 81(2):184-91. PubMed ID: 5764682 [No Abstract] [Full Text] [Related]
19. Effect of short-term (5-15 days) topical dexamethasone treatment on intraocular pressure. Lehrer JA Eye Ear Nose Throat Mon; 1970 May; 49(5):249-52. PubMed ID: 5480300 [No Abstract] [Full Text] [Related]
20. Pseudofacility in the human eye. Kupfer C Trans Am Ophthalmol Soc; 1971; 69():383-96. PubMed ID: 5154269 [No Abstract] [Full Text] [Related] [Next] [New Search]